Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs

Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs

US Patent 11098291 · Granted Aug 24, 2021

Estimated economic value: $11,367,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered transaminase polypeptides2025
Engineered galactose oxidase variant enzymes2025
Ketoreductase polypeptides for the preparation of phenylephrine2025
Penicillin-G acylases2025
Engineered deoxyribose-phosphate aldolases2025
Engineered phosphopentomutase variant enzymes2025
Polynucleotides encoding engineered imine reductases2025
Polynucleotides encoding engineered imine reductases2025
Polynucleotides encoding engineered imine reductases2025
Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptami2025
Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptami2025
Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptami2025